BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26906450)

  • 1. Expanding the library of divalent fucosidase inhibitors with polyamino and triazole-benzyl bridged bispyrrolidines.
    Hottin A; Carrión-Jiménez S; Moreno-Clavijo E; Moreno-Vargas AJ; Carmona AT; Robina I; Behr JB
    Org Biomol Chem; 2016 Mar; 14(12):3212-20. PubMed ID: 26906450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spirocyclopropyl pyrrolidines as a new series of alpha-L-fucosidase inhibitors.
    Laroche C; Behr JB; Szymoniak J; Bertus P; Schütz C; Vogel P; Plantier-Royon R
    Bioorg Med Chem; 2006 Jun; 14(12):4047-54. PubMed ID: 16488612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'mirror-image' postulate as a guide to the selection and evaluation of pyrrolidines as α-l-fucosidase inhibitors.
    Stocker BL; Jongkees SA; Win-Mason AL; Dangerfield EM; Withers SG; Timmer MS
    Carbohydr Res; 2013 Feb; 367():29-32. PubMed ID: 23295913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the divalent effect in fucosidase inhibition with stereoisomeric pyrrolidine dimers.
    Hottin A; Wright DW; Moreno-Clavijo E; Moreno-Vargas AJ; Davies GJ; Behr JB
    Org Biomol Chem; 2016 May; 14(20):4718-27. PubMed ID: 27138139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases.
    Moreno-Clavijo E; Carmona AT; Vera-Ayoso Y; Moreno-Vargas AJ; Bello C; Vogel P; Robina I
    Org Biomol Chem; 2009 Mar; 7(6):1192-202. PubMed ID: 19262940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and fucosidase inhibitory study of unnatural pyrrolidine alkaloid 4-epi-(+)-codonopsinine.
    Kotland A; Accadbled F; Robeyns K; Behr JB
    J Org Chem; 2011 May; 76(10):4094-8. PubMed ID: 21495694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective synthesis of (2S,3S,4R,5S)-5-methylpyrrolidine-3,4-diol derivatives that are highly selective alpha-L-fucosidase inhibitors.
    Moreno-Vargas AJ; Carmona AT; Mora F; Vogel P; Robina I
    Chem Commun (Camb); 2005 Oct; (39):4949-51. PubMed ID: 16205810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing pyrrolidine iminosugars into dimeric structures for the rapid discovery of divalent glycosidase inhibitors.
    Carmona AT; Carrión-Jiménez S; Pingitore V; Moreno-Clavijo E; Robina I; Moreno-Vargas AJ
    Eur J Med Chem; 2018 May; 151():765-776. PubMed ID: 29674295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting the hydrophobic terrain in fucosidases with aryl-substituted pyrrolidine iminosugars.
    Hottin A; Wright DW; Davies GJ; Behr JB
    Chembiochem; 2015 Jan; 16(2):277-83. PubMed ID: 25427942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of all-cis 2,5-imino-2,5-dideoxy-fucitol and its evaluation as a potent fucosidase and galactosidase inhibitor.
    Ak A; Prudent S; LeNouën D; Defoin A; Tarnus C
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7410-3. PubMed ID: 21050758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid discovery of potent α-fucosidase inhibitors by in situ screening of a library of (pyrrolidin-2-yl)triazoles.
    Elías-Rodríguez P; Moreno-Clavijo E; Carmona AT; Moreno-Vargas AJ; Robina I
    Org Biomol Chem; 2014 Aug; 12(31):5898-904. PubMed ID: 24984102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three dimensional structure of a bacterial α-l-fucosidase with a 5-membered iminocyclitol inhibitor.
    Wright DW; Moreno-Vargas AJ; Carmona AT; Robina I; Davies GJ
    Bioorg Med Chem; 2013 Aug; 21(16):4751-4. PubMed ID: 23830696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 4-amino-4,5-dideoxy-L-lyxofuranose derivatives and their evaluation as fucosidase inhibitors.
    Chevrier C; Le Nouën D; Defoin A; Tarnus C
    Carbohydr Res; 2011 Jul; 346(10):1202-11. PubMed ID: 21550024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-L-fucosidase inhibition by pyrrolidine-ferrocene hybrids: rationalization of ligand-binding properties by structural studies.
    Hottin A; Wright DW; Steenackers A; Delannoy P; Dubar F; Biot C; Davies GJ; Behr JB
    Chemistry; 2013 Jul; 19(29):9526-33. PubMed ID: 23740878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second-generation ferrocene-iminosugar hybrid with improved fucosidase binding properties.
    Hottin A; Scandolera A; Duca L; Wright DW; Davies GJ; Behr JB
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1546-1549. PubMed ID: 26897594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid diversity-oriented synthesis in microtiter plates for in situ screening: discovery of potent and selective alpha-fucosidase inhibitors.
    Wu CY; Chang CF; Chen JS; Wong CH; Lin CH
    Angew Chem Int Ed Engl; 2003 Oct; 42(38):4661-4. PubMed ID: 14533157
    [No Abstract]   [Full Text] [Related]  

  • 17. Asymmetric synthesis of the L-fuco-nojirimycin, a nanomolar alpha-L-fucosidase inhibitor.
    Dubernet M; Defoin A; Tarnus C
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1172-4. PubMed ID: 16376079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses and biological activities of 1,4-iminoalditol derivatives as alpha-L-fucosidase inhibitors.
    Moreno-Clavijo E; Carmona AT; Moreno-Vargas AJ; Molina L; Robina I
    Chimia (Aarau); 2011; 65(1-2):40-4. PubMed ID: 21469443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and thermodynamic analyses of α-L-fucosidase inhibitors.
    Lammerts van Bueren A; Popat SD; Lin CH; Davies GJ
    Chembiochem; 2010 Sep; 11(14):1971-4. PubMed ID: 20665773
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of fucosyltransferase and fucosidase inhibitors.
    Tu Z; Lin YN; Lin CH
    Chem Soc Rev; 2013 May; 42(10):4459-75. PubMed ID: 23588106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.